← All trials
NCT00235729
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2006
- Primary completion
- Oct 1, 2007
- Completion date
- Oct 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 264
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Department of Veteran AffairsLead sponsor
- Department of Veteran AffairsStudy chair
- National Institute on Drug Abuse (NIDA)Collaborator
- US WorldMedsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.